On Monday, Paris-based French drugmaker Sanofi announced plans to invest more than €1 billion at three facilities in France to create new bioproduction capacity.
Life science group Sartorius and biopharmaceutical firm Sanofi are partnering to create a platform for continuous downstream bioprocessing. Sartorius will use its...
Contract manufacturing and development organization (CDMO) Wacker Biotech US, a subsidiary of Germany’ Wacker Chemie specializing in the fermentative production of...
Agilent Technologies and Merck have made significant progress in their collaboration, launched in 2022, to enhance bioprocessing. The partnership integrates Process...
Aragen, a CRDMO, has launched the first phase of its biologics manufacturing facility in Bangalore, India. The $30 million project, executed by its subsidiary Aragen...
Merck is pouring over €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. This marks the largest investment by Merck's Life Science sector in...
Greentech firm Afyren Neoxy, a subsidiary of Afyren, received a €3.4 million payment this week for achieving key milestones with its bio-based low-carbon products.
